We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AENZ
3226
DELISTED
Aenza S.A.A.
AENZ
$117K ﹤0.01%
12,820
CMBT
3227
CMB.TECH NV
CMBT
$4.67B
$115K ﹤0.01%
13,900
HOV icon
3228
Hovnanian Enterprises
HOV
$772M
$113K ﹤0.01%
2,468
+2,000
+427% +$115K
MHI
3229
DELISTED
Pioneer Municipal High Income Fund
MHI
$113K ﹤0.01%
10,032
-53
-0.5% -$608
NE
3230
DELISTED
Noble Corporation
NE
$113K ﹤0.01%
30,560
-6,339
-17% -$28.2K
KTOS icon
3231
Kratos Defense & Security Solutions
KTOS
$11.7B
$112K ﹤0.01%
10,852
-5,870
-35% -$65.4K
INSY
3232
DELISTED
Insys Therapeutics, Inc.
INSY
$110K ﹤0.01%
18,233
-12,775
-41% -$105K
JOB icon
3233
GEE Group
JOB
$22.1M
$108K ﹤0.01%
40,853
SJT
3234
San Juan Basin Royalty Trust
SJT
$121M
$108K ﹤0.01%
+13,700
New +$122K
SIRI icon
3235
CALL
SiriusXM
SIRI
$9.7B
$107K ﹤0.01%
11,910
+5,000
+72% +$300K
GLDD
3236
DELISTED
Great Lakes Dredge & Dock
GLDD
$106K ﹤0.01%
23,044
-135,030
-85% -$641K
INB
3237
DELISTED
Cohen & Steers Global Income Builder, Inc.
INB
$106K ﹤0.01%
11,618
+817
+8% +$7.89K
DAKT icon
3238
Daktronics
DAKT
$1.03B
$105K ﹤0.01%
11,920
-925
-7% -$8.52K
DRH icon
3239
Diamondrock Hospitality Co
DRH
$2.48B
$105K ﹤0.01%
10,054
TRUE
3240
DELISTED
TrueCar
TRUE
$104K ﹤0.01%
11,000
-1,250
-10% -$13.9K
UUU icon
3241
Universal Safety Products Inc
UUU
$10.9M
$104K ﹤0.01%
73,513
WVVI icon
3242
Willamette Valley Vineyards
WVVI
$11.7M
$104K ﹤0.01%
13,075
BKT icon
3243
BlackRock Income Trust
BKT
$342M
$102K ﹤0.01%
5,778
-316
-5% -$5.62K
CRM icon
3244
CALL
Salesforce
CRM
$162B
$101K ﹤0.01%
14,200
-400
-3% -$45.9K
SRF
3245
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$101K ﹤0.01%
11,627
-2,080
-15% -$19.1K
TLGT
3246
DELISTED
Teligent, Inc
TLGT
$100K ﹤0.01%
2,990
+910
+44% +$28.9K
JHY
3247
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
$99K ﹤0.01%
10,072
-1,124
-10% -$11.1K
CRBP icon
3248
Corbus Pharmaceuticals
CRBP
$177M
$97K ﹤0.01%
+530
New +$119K
JCP
3249
DELISTED
J.C. Penney Company, Inc.
JCP
$97K ﹤0.01%
32,225
-248
-0.8% -$894
EOD
3250
Allspring Global Dividend Opportunity Fund
EOD
$286M
$96K ﹤0.01%
16,876
-1,619
-9% -$9.45K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.